Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiziana Vaisitti

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Sciences|April 13, 2018
Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?Tiziana Vaisitti, Francesca Arruga, Silvia Deaglio
Cancers|September 9, 2020
Chronic Lymphocytic LeukemiaTiziana Vaisitti, Francesca Arruga, Alessandra Ferrajoli
Current Treatment Options in Oncology|March 16, 2022
Novel Approaches for the Treatment of Patients with Richter's SyndromeAndrea Iannello, Silvia Deaglio, Tiziana Vaisitti
Frontiers in Oncology|December 12, 2018
The NOTCH Pathway and Its Mutations in Mature B Cell MalignanciesFrancesca Arruga, Tiziana Vaisitti, Silvia Deaglio
Cancer Letters|March 23, 2022
Lift the curtain on long non-coding RNAs in hematological malignancies: Pathogenic elements and potential targetsAndrea Iannello, Alessia Ciarrocchi, Valentina Fragliasso, et al.
Frontiers in Immunology|October 23, 2019
Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic TargetsTiziana Vaisitti, Francesca Arruga, Giulia Guerra, et al.
International Journal of Molecular Sciences|January 28, 2026
Antibody-Drug Conjugates in Hematological Malignancies: Current Landscape and Future PerspectivesMaria Chiara Montalbano, Matilde Micillo, Silvia Deaglio, et al.
Blood|April 20, 2006
In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemiaSilvia Deaglio, Tiziana Vaisitti, Semra Aydin, et al.
Trends in Molecular Medicine|April 12, 2008
CD38 at the junction between prognostic marker and therapeutic targetSilvia Deaglio, Semra Aydin, Tiziana Vaisitti, et al.
Seminars in Cancer Biology|September 7, 2010
CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cellsSilvia Deaglio, Tiziana Vaisitti, Antonella Zucchetto, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|April 13, 2018
Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?Tiziana Vaisitti, Francesca Arruga, Silvia Deaglio
Cancers|September 9, 2020
Chronic Lymphocytic LeukemiaTiziana Vaisitti, Francesca Arruga, Alessandra Ferrajoli
Current Treatment Options in Oncology|March 16, 2022
Novel Approaches for the Treatment of Patients with Richter's SyndromeAndrea Iannello, Silvia Deaglio, Tiziana Vaisitti
Frontiers in Oncology|December 12, 2018
The NOTCH Pathway and Its Mutations in Mature B Cell MalignanciesFrancesca Arruga, Tiziana Vaisitti, Silvia Deaglio
Cancer Letters|March 23, 2022
Lift the curtain on long non-coding RNAs in hematological malignancies: Pathogenic elements and potential targetsAndrea Iannello, Alessia Ciarrocchi, Valentina Fragliasso, et al.
Frontiers in Immunology|October 23, 2019
Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic TargetsTiziana Vaisitti, Francesca Arruga, Giulia Guerra, et al.
International Journal of Molecular Sciences|January 28, 2026
Antibody-Drug Conjugates in Hematological Malignancies: Current Landscape and Future PerspectivesMaria Chiara Montalbano, Matilde Micillo, Silvia Deaglio, et al.
Blood|April 20, 2006
In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemiaSilvia Deaglio, Tiziana Vaisitti, Semra Aydin, et al.
Trends in Molecular Medicine|April 12, 2008
CD38 at the junction between prognostic marker and therapeutic targetSilvia Deaglio, Semra Aydin, Tiziana Vaisitti, et al.
Seminars in Cancer Biology|September 7, 2010
CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cellsSilvia Deaglio, Tiziana Vaisitti, Antonella Zucchetto, et al.
Pageof 8